Apollo Endosurgery, Inc.

APEN · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Operating Activities
Net Income-$9,553-$11,446-$10,426-$8,414
Dep. & Amort.$719$769$737$741
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,710$1,860$1,657$1,556
Change in WC-$789-$2,010-$1,257-$2,882
Other Non-Cash-$2,390$4,631$3,215$310
Operating Cash Flow-$10,303-$6,196-$6,074-$8,689
Investing Activities
PP&E Inv.-$512-$1,126-$556-$551
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0-$84
Investing Cash Flow-$512-$1,126-$556-$551
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$1,226$0$0$613
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$371$24-$78$32
Financing Cash Flow$371$24-$78$32
Forex Effect$541-$531-$286$134
Net Chg. in Cash-$9,903-$7,829-$6,994-$9,074
Supplemental Information
Beg. Cash$67,915$75,744$82,738$91,812
End Cash$58,012$67,915$75,744$82,738
Free Cash Flow-$10,815-$7,322-$6,630-$9,240
Apollo Endosurgery, Inc. (APEN) Financial Statements & Key Stats | AlphaPilot